Statins, angiotensin converting enzyme inhibitors and angiotensin receptor II blockers were used mainly by MetS- or CHD-affected subjects and thus their independent effect on the efflux values could not be evaluated. The gene discussed is ACE; the disease is metabolic syndrome.